Novartis $NVS stock is testing a Bullish FlagThe bullish flag breakout pattern is a popular chart pattern in technical analysis that signals the continuation of an uptrend. It typically forms after a strong price surge, where... breakout as of June 9, 2023. NVS stock is trading in a technical strong uptrend.

Novartis AG is a Swiss multinational pharmaceutical company that specializes in the research, development, manufacturing, and marketing of prescription drugs, generics, biosimilars, and eye care products. The company operates in over 140 countries and has a diverse portfolio of products across several therapeutic areas, including cardiovascular, immunology and dermatology, neuroscience, oncology, respiratory, and more. Novartis also has a strong focus on innovation and invests heavily in research and development, with a goal to bring life-changing medicines to patients around the world.

Sandoz, the generics drug business of Novartis, announced plans to raise its salesThe income statement provides a summary of a company's revenue and expenses over a specified period of time, typically a year or a quarter. It shows the company's total revenue, th... growth and EBITDA margins following its planned spinoff expected in H2 2023.

The company focused on off-patent medications called generics and biosimilars also intends to generate an additional $3B in net sales over the next five years.